Labcorp EVP Brian J. Caveney Disposes of Common Shares

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Labcorp FY 2025 restructuring and other charges rise 176.5% to USD 127.2 million

Labcorp Holdings Is Maintained at Neutral by Piper Sandler

Labcorp Holdings (LH) Receives a Hold from Piper Sandler

Piper Sandler Adjusts Price Target on Labcorp Holdings to $300 From $270, Maintains Neutral Rating

U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies

Labcorp SVP and Chief Accounting Officer Peter J. Wilkinson Disposes of Common Shares

BRIEF-Labcorp Expands Collaboration With Pathai To Deploy FDA-Cleared Digital Pathology Platform

Labcorp Expands Collaboration With PathAI to Deploy AISight Dx Nationwide

Labcorp Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Rothschild & Co Redburn Adjusts Labcorp Price Target to $325 From $303, Maintains Buy Rating

CHS - Community Health Systems Inc. reports Q4 net income attributable to stockholders of USD 110.00 million

Labcorp Holdings (LH) Receives a Buy from Evercore ISI

Labcorp Holdings Is Maintained at Outperform by Baird

Analysts Conflicted on These Healthcare Names: Baxter International (BAX), Labcorp Holdings (LH) and Vertex Pharmaceuticals (VRTX)

Labcorp price target raised to $326 from $313 at Baird

Baird Adjusts Price Target on Labcorp Holdings to $326 From $313, Maintains Outperform Rating

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Icon (ICLR) and Labcorp Holdings (LH)